New clinical trial investigates aspirin as part of new treatment for triple negative

[News]

An innovative new study is trialing whether giving aspirin, commonly used as pain relief, alongside immunotherapy drug avelumab could improve its effectiveness for people affected by breast cancer.

More... (https://www.news-medical.net/news/20210817/New-clinical-trial-investigates-aspirin-as-part-of-new-treatment-for-triple-negative-breast-cancer.aspx)